The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UC San Francisco researchers have found in a new study.

One of the world’s preeminent cancer scientists, Alan Ashworth, PhD, FRS, has been appointed the new director of the UCSF Helen Diller Family Comprehensive Cancer Center.  

Laura van 't Veer, PhD, was honored this week as one of the top female scientific innovators in Europe. 

E-cigarettes, promoted as a way to quit regular cigarettes, may actually be a new route to conventional smoking and nicotine addiction for teenagers, according to a new UC San Francisco study.

Pancreatic cancer, compared to other types of leading cancer killers, is detected later and does not respond well to either new or established drugs. Now a new UC San Francisco study has shed light on the origins of one type of deadly pancreatic cancer.

Joel Palefsky, MD, is the director of the Clinical and Translational Research Fellowship Program (CTRFP) at CTSI. Note: Dr. Palefsky was recently awarded an $89 million grant from the National Cancer Institute for a major investigation of anal cancer.